BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30599844)

  • 1. Dual-energy computed tomography for prediction of loco-regional recurrence after radiotherapy in larynx and hypopharynx squamous cell carcinoma.
    Bahig H; Lapointe A; Bedwani S; de Guise J; Lambert L; Filion E; Roberge D; Létourneau-Guillon L; Blais D; Ng SP; Nguyen-Tan PF
    Eur J Radiol; 2019 Jan; 110():1-6. PubMed ID: 30599844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage radiotherapy for recurrent hypopharyngeal and laryngeal squamous cell carcinoma (SCC) after first-line treatment with surgery alone: a 10-year single-centre experience.
    Akbaba S; Held T; Lang K; Hoerner-Rieber J; Zaoui K; Forster T; Rieken S; Plinkert P; Debus J; Adeberg S
    Radiat Oncol; 2019 Feb; 14(1):34. PubMed ID: 30782197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definitive intensity modulated radiotherapy in locally advanced hypopharygeal and laryngeal squamous cell carcinoma: mature treatment results and patterns of locoregional failure.
    Geretschläger A; Bojaxhiu B; Dal Pra A; Leiser D; Schmücking M; Arnold A; Ghadjar P; Aebersold DM
    Radiat Oncol; 2015 Jan; 10():20. PubMed ID: 25595218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning-based FDG PET-CT radiomics for outcome prediction in larynx and hypopharynx squamous cell carcinoma.
    Zhong J; Frood R; Brown P; Nelstrop H; Prestwich R; McDermott G; Currie S; Vaidyanathan S; Scarsbrook AF
    Clin Radiol; 2021 Jan; 76(1):78.e9-78.e17. PubMed ID: 33036778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.
    Keek S; Sanduleanu S; Wesseling F; de Roest R; van den Brekel M; van der Heijden M; Vens C; Giuseppina C; Licitra L; Scheckenbach K; Vergeer M; Leemans CR; Brakenhoff RH; Nauta I; Cavalieri S; Woodruff HC; Poli T; Leijenaar R; Hoebers F; Lambin P
    PLoS One; 2020; 15(5):e0232639. PubMed ID: 32442178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laryngeal or hypopharyngeal squamous cell carcinoma: can follow-up CT after definitive radiation therapy be used to detect local failure earlier than clinical examination alone?
    Hermans R; Pameijer FA; Mancuso AA; Parsons JT; Mendenhall WM
    Radiology; 2000 Mar; 214(3):683-7. PubMed ID: 10715030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of intensity-modulated radiotherapy versus conventional radiotherapy for hypopharyngeal cancer.
    Mok G; Gauthier I; Jiang H; Huang SH; Chan K; Witterick IJ; O'Sullivan B; Waldron JN; Bayley AJ; Cho BC; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; Ringash J
    Head Neck; 2015 May; 37(5):655-61. PubMed ID: 24590756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence patterns after postoperative radiotherapy for squamous cell carcinoma of the pharynx and larynx.
    Iizuka Y; Yoshimura M; Inokuchi H; Matsuo Y; Nakamura A; Mizowaki T; Hirano S; Kitamura M; Tateya I; Hiraoka M
    Acta Otolaryngol; 2015 Jan; 135(1):96-102. PubMed ID: 25351439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography.
    Stokkel MP; Terhaard CH; Hordijk GJ; van Rijk PP
    Eur J Nucl Med; 1999 Jul; 26(7):767-73. PubMed ID: 10398825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for local-regional recurrence following preoperative radiation therapy and surgery for head and neck cancer (stage II-IVB).
    Shikama N; Sasaki S; Nishikawa A; Koiwai K; Yoshino F; Hirase Y; Kawakami R; Kadoya M; Oguchi M
    Radiology; 2003 Sep; 228(3):789-94. PubMed ID: 12954897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
    Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer.
    Chen AM; Farwell DG; Luu Q; Chen LM; Vijayakumar S; Purdy JA
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1423-9. PubMed ID: 20656416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules.
    Garden AS; Morrison WH; Ang KK; Peters LJ
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):493-502. PubMed ID: 7852111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypopharynx and larynx cancers: propositions for the selection and the delineation of peritumoral microscopic disease volumes (lymph nodes excluded)].
    Lapeyre M; Bailly C; Toledano I; Montalban A; Russier M
    Cancer Radiother; 2010 Nov; 14 Suppl 1():S43-51. PubMed ID: 21129669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.
    Krstevska V; Crvenkova S
    Croat Med J; 2006 Feb; 47(1):42-52. PubMed ID: 16489696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of total tumor volume in advanced-stage laryngeal and hypopharyngeal carcinoma.
    Yang CJ; Kim DY; Lee JH; Roh JL; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2013 Dec; 108(8):509-15. PubMed ID: 24590673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical radiotherapy for squamous cell carcinoma of the larynx, oropharynx and hypopharynx: patterns of recurrence, treatment and survival.
    Jones AS; Husband D; Rowley H
    Clin Otolaryngol Allied Sci; 1998 Dec; 23(6):496-511. PubMed ID: 9884802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery.
    Levendag P; Braaksma M; Coche E; van Der Est H; Hamoir M; Muller K; Noever I; Nowak P; van Sörensen De Koste J; Grégoire V
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):113-23. PubMed ID: 14697428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx.
    Daly ME; Le QT; Jain AK; Maxim PG; Hsu A; Loo BW; Kaplan MJ; Fischbein NJ; Colevas AD; Pinto H; Chang DT
    Head Neck; 2011 Jan; 33(1):103-11. PubMed ID: 20848427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.